{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:35:29Z","timestamp":1795041329607,"version":"4.10.2"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The use of regional and other opioid-sparing forms of anesthesia has been associated with a decrease in the recurrence of certain malignancies. Direct suppression of human natural killer cells by opioids has been postulated to explain this observation. However, the effect of different classes of opioids on suppression of natural killer cell cytotoxicity has not been systematically characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>After confirming that freshly isolated natural killer cells from peripheral human blood express opioid receptors, cells were incubated with increasing concentrations of clinically used or receptor-specific opioid agonists. We also evaluated the effect of pretreatment with receptor-specific antagonists or naloxone. Treated natural killer cells were then coincubated with a carboxyfluorescein succinimidyl ester\u2013labeled target tumor cell line, K562. Annexin V staining was used to compare the percent of tumor cell apoptosis in the presence of opioid-pretreated and untreated natural killer cells. Treated samples were compared to untreated samples using Kruskal-Wallis tests with a post hoc Dunn correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Morphine, methadone, buprenorphine, loperamide, [\n                      <jats:sc>d<\/jats:sc>\n                      -Ala2,\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -MePhe4, Gly-ol]-enkephalin, and U-50488 significantly decreased natural killer cell cytotoxicity. When natural killer cells were pretreated with naloxone, cyprodime, and nor-binaltorphimine before exposure to morphine, there was no difference in natural killer cytotoxicity, compared to the amount observed by untreated natural killer cells. Fentanyl,\n                      <jats:italic toggle=\"yes\">O<\/jats:italic>\n                      -desmethyltramadol, and [D-Pen2,D-Pen5] enkephalin did not change natural killer cell cytotoxicity compare to untreated natural killer cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Incubation of isolated natural killer cells with certain opioids causes a decrease in activity that is not observed after naloxone pretreatment. Suppression of natural killer cell cytotoxicity was observed with \u03bc- and \u03ba-receptor agonists but not \u03b4-receptor agonists. These data suggest that the effect is mediated by \u03bc- and \u03ba-receptor agonism and that suppression is similar with many clinically used opioids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000004058","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T21:20:03Z","timestamp":1551475203000},"page":"1013-1021","source":"Crossref","is-referenced-by-count":56,"title":["Suppression of Human Natural Killer Cells by Different Classes of Opioids"],"prefix":"10.1213","volume":"128","author":[{"given":"Dermot P.","family":"Maher","sequence":"first","affiliation":[{"name":"From the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Walia","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola M.","family":"Heller","sequence":"additional","affiliation":[{"name":"From the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-20230721","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1093\/bja\/aeu192","article-title":"Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis.","volume":"113","author":"Maher","year":"2014","journal-title":"Br J Anaesth"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00000542-200610000-00008","article-title":"Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?","volume":"105","author":"Exadaktylos","year":"2006","journal-title":"Anesthesiology"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ALN.0b013e31817f5b73","article-title":"Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis.","volume":"109","author":"Biki","year":"2008","journal-title":"Anesthesiology"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/AIA.0000000000000123","article-title":"An update on existing ongoing prospective trials evaluating the effect of anesthetic and analgesic techniques during primary cancer surgery on cancer recurrence or metastasis.","volume":"54","author":"Royds","year":"2016","journal-title":"Int Anesthesiol Clin"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bmjspcare-2013-000573","article-title":"A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function.","volume":"4","author":"Boland","year":"2014","journal-title":"BMJ Support Palliat Care"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinane.2015.05.010","article-title":"Proposed mechanisms for association between opioid usage and cancer recurrence after surgery.","volume":"28","author":"Maher","year":"2016","journal-title":"J Clin Anesth"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","article-title":"Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism.","volume":"29","author":"Bayer","year":"1990","journal-title":"Neuropharmacology"},{"key":"R8-20230721","first-page":"255","article-title":"Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells.","volume":"24","author":"Fuggetta","year":"2005","journal-title":"J Exp Clin Cancer Res"},{"key":"R9-20230721","first-page":"492","article-title":"Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period.","volume":"82","author":"Beilin","year":"1996","journal-title":"Anesth Analg"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0192-0561(96)00011-2","article-title":"Comparison of the in vivo effects of morphine and methadone on natural killer cell activity in spleen, peritoneal cavity, and lungs in rats.","volume":"18","author":"Van der Laan","year":"1996","journal-title":"Int J Immunopharmacol"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients.","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth Analg"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpain.2012.02.005","article-title":"(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.","volume":"13","author":"Lewis","year":"2012","journal-title":"J Pain"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humimm.2016.11.006","article-title":"Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.","volume":"78","author":"Phan","year":"2017","journal-title":"Hum Immunol"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12264-012-1219-5","article-title":"Emerging role of Toll-like receptors in the control of pain and itch.","volume":"28","author":"Liu","year":"2012","journal-title":"Neurosci Bull"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5055\/jom.2016.0348","article-title":"Clinically relevant concentrations of opioids for in vitro studies.","volume":"12","author":"Boland","year":"2016","journal-title":"J Opioid Manag"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-1759(01)00507-5","article-title":"An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity.","volume":"259","author":"Fischer","year":"2002","journal-title":"J Immunol Methods"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L","article-title":"Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity.","volume":"37","author":"Aubry","year":"1999","journal-title":"Cytometry"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"e19820","DOI":"10.1371\/journal.pone.0019820","article-title":"Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation.","volume":"6","author":"Oliver","year":"2011","journal-title":"PLoS One"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system - friend or foe.","volume":"175","author":"Plein","year":"2018","journal-title":"Br J Pharmacol"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/brbi.1999.0575","article-title":"Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.","volume":"14","author":"Nelson","year":"2000","journal-title":"Brain Behav Immun"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000542-199509000-00008","article-title":"Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers.","volume":"83","author":"Yeager","year":"1995","journal-title":"Anesthesiology"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.intimp.2004.01.011","article-title":"Buprenorphine produces naltrexone reversible alterations of immune status.","volume":"4","author":"Carrigan","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5055\/jom.2008.0005","article-title":"Relationship between fentanyl dosage and immune function in the postoperative period.","volume":"4","author":"Yardeni","year":"2008","journal-title":"J Opioid Manag"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-5728(02)00165-0","article-title":"The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats.","volume":"129","author":"Gaspani","year":"2002","journal-title":"J Neuroimmunol"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/AJP.0000000000000338","article-title":"Comparison between the effects of intravenous morphine, tramadol, and ketorolac on stress and immune responses in patients undergoing modified radical mastectomy.","volume":"32","author":"Bakr","year":"2016","journal-title":"Clin J Pain"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0014-2999(96)00770-4","article-title":"Tramadol, M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells.","volume":"316","author":"Lai","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement.","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J Neurosci"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects.","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav Immun"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses.","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s11999-015-4173-5","article-title":"Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery.","volume":"473","author":"Menendez","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/cmi.2009.15","article-title":"Acute morphine administration reduces cell-mediated immunity and induces reactivation of latent herpes simplex virus type 1 in BALB\/c mice.","volume":"6","author":"Mojadadi","year":"2009","journal-title":"Cell Mol Immunol"},{"key":"R32-20230721","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1189\/jlb.0305167","article-title":"Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells.","volume":"78","author":"Wang","year":"2005","journal-title":"J Leukoc Biol"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"e1333","DOI":"10.1097\/MD.0000000000001333","article-title":"Effect of mu agonists on long-term survival and recurrence in nonsmall cell lung cancer patients.","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1213\/00000539-198804000-00004","article-title":"Recurrent herpes simplex virus labialis and the use of epidural morphine in obstetric patients.","volume":"67","author":"Crone","year":"1988","journal-title":"Anesth Analg"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/ALN.0b013e31824babe2","article-title":"Overexpression of the \u03bc-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"key":"R36-20230721","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"issue":"suppl 1","key":"R37-20230721","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/bja\/aeu090","article-title":"Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.","volume":"113","author":"Nguyen","year":"2014","journal-title":"Br J Anaesth"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbi.2011.12.010","article-title":"Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.","volume":"26","author":"Franchi","year":"2012","journal-title":"Brain Behav Immun"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1124\/mol.108.046029","article-title":"T-cell receptor\/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.","volume":"74","author":"B\u00f6rner","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.0802763","article-title":"Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.","volume":"183","author":"B\u00f6rner","year":"2009","journal-title":"J Immunol"},{"key":"R41-20230721","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0889-1591(89)90013-5","article-title":"Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats.","volume":"3","author":"Beilin","year":"1989","journal-title":"Brain Behav Immun"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.intimp.2013.11.015","article-title":"Effects of opioid therapy on human natural killer cells.","volume":"18","author":"Tabellini","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"R43-20230721","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3344\/kjp.2018.31.1.43","article-title":"Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain.","volume":"31","author":"Yoon","year":"2018","journal-title":"Korean J Pain"},{"key":"R44-20230721","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3959(00)00403-6","article-title":"Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats.","volume":"90","author":"Page","year":"2001","journal-title":"Pain"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201905000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:21:15Z","timestamp":1786112475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201905000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004058","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}